PHENERGAN Side Effects

6993021-6 | Anxiety, Hallucination, Malaise, Nightmare, Thinking Abnormal
on Sep 16, 2010 Female patient from UNITED STATES , 82 years of age, weighting 154.0 lb, was diagnosed with nausea (What is nausea?) and was treated with Phenergan (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), hallucination, malaise, nightmare, thinking abnormal. Phenergan dosage: Once Iv Drip.

6937560-2 | Accidental Overdose, Hepatomegaly, Pulmonary Oedema
Patient was taking Phenergan (View Usage). Patient had the following side effects: accidental overdose, hepatomegaly, pulmonary oedema on Aug 23, 2010 from UNITED STATES Additional patient health information: Female patient , 31 years of age, weighting 214.0 lb, was diagnosed with nausea (What is nausea?) and. Phenergan dosage: Rectal.

6917660-3 | Fatigue
Adverse event was reported on Oct 29, 2008 by a Female patient taking Phenergan (View Usage) (Dosage: ) was diagnosed with nasopharyngitis, narcolepsy and. Location: UNITED STATES , weighting 125.1 lb, After Phenergan was administered, patient had the following side effects: fatigue. During the same period patient was treated with XYREM (View Xyrem Review and Xyrem Label ).

6917658-5 | Unevaluable Event
on Jun 18, 2008 Male patient from UNITED STATES , weighting 148.1 lb, was treated with Phenergan (View Usage). Patient experienced the following unwanted or unexpected effects: unevaluable event. Phenergan dosage: .


6916850-3 | Cyst, Dyspnoea, Fall, Immediate Post-injection Reaction, Monoplegia, Pain, Pain In Extremity, Urticaria, Weight Bearing Difficulty
on Aug 09, 2010 Female patient from UNITED STATES , 52 years of age, weighting 110.0 lb, was diagnosed with migraine (What is migraine?) and was treated with Phenergan (View Usage). Patient had the following side effects: cyst, dyspnoea, fall (What is fall?), immediate post-injection reaction, monoplegia, pain (What is pain?), pain in extremity, urticaria, weight bearing difficulty. Phenergan dosage: 3 Times Im.

6869475-2 | Asthenia, Eye Pain, Movement Disorder, Nerve Injury, Screaming, Vein Pain, Visual Impairment
Patient was taking Phenergan (View Usage). After Phenergan was administered, patient had the following side effects: asthenia, eye pain, movement disorder (What is movement disorder?), nerve injury, screaming, vein pain, visual impairment on Jul 21, 2010 from UNITED STATES Additional patient health information: Female patient , 64 years of age, weighting 148.0 lb, was diagnosed with nausea (What is nausea?), pleurisy and. Phenergan dosage: 12mg 1 Iv ; 25mg 1 Iv.

6840772-X | Angiopathy, Burning Sensation, Chest Pain, Depression, Headache, Infertility, Injection Site Pain, Loss Of Consciousness
Adverse event was reported on Jul 07, 2010 by a Male patient taking Phenergan (View Usage) (Dosage: ) . Location: UNITED STATES , 50 years of age, Patient experienced the following unwanted or unexpected effects: angiopathy, burning sensation, chest pain (What is chest pain?), depression (What is depression?), headache (What is headache?), infertility (What is infertility?), injection site pain, loss of consciousness. During the same period patient was treated with SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (View Sodium Chloride 0.9% In Plastic Container Review and Sodium Chloride 0.9% In Plastic Container Label ), ESZOPICLONE (View Eszopiclone Review and Eszopiclone Label ), HYDROCO/APA (View Hydroco/apa Review and Hydroco/apa Label ).

6832299-6 | Burning Sensation, Cyanosis, Dry Gangrene, Ecchymosis, Extremity Necrosis, Headache, Ischaemia, Pain, Raynaud's Phenomenon
on Jul 01, 2010 Female patient from UNITED STATES , 47 years of age, was treated with Phenergan (View Usage). Patient had the following side effects: burning sensation, cyanosis, dry gangrene, ecchymosis, extremity necrosis, headache (What is headache?), ischaemia, pain (What is pain?), raynaud's phenomenon. Phenergan dosage: .

6823548-9 | Angiopathy, Burning Sensation, Chest Pain, Depression, Headache, Infertility, Injection Site Pain, Loss Of Consciousness
on Jun 29, 2010 Male patient from UNITED STATES , 50 years of age, was treated with Phenergan (View Usage). After Phenergan was administered, patient had the following side effects: angiopathy, burning sensation, chest pain (What is chest pain?), depression (What is depression?), headache (What is headache?), infertility (What is infertility?), injection site pain, loss of consciousness. Phenergan dosage: . During the same period patient was treated with SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (View Sodium Chloride 0.9% In Plastic Container Review and Sodium Chloride 0.9% In Plastic Container Label ), ESZOPICLONE (View Eszopiclone Review and Eszopiclone Label ), HYDROCO/APA (View Hydroco/apa Review and Hydroco/apa Label ).

6821766-7 | Hypoaesthesia, Injection Site Pain, Nerve Injury
Patient was taking Phenergan (View Usage). Patient experienced the following unwanted or unexpected effects: hypoaesthesia, injection site pain, nerve injury on Jul 07, 2010 from UNITED STATES Additional patient health information: Female patient , 30 years of age, weighting 130.0 lb, was diagnosed with nausea (What is nausea?) and. Phenergan dosage: Once Sq.

6794822-X | Convulsion
Adverse event was reported on Jun 24, 2010 by a Female patient taking Phenergan (View Usage) (Dosage: Once Iv) was diagnosed with nausea (What is nausea?) and. Location: UNITED STATES , weighting 200.0 lb, Patient had the following side effects: convulsion.

6786141-2 | Catheter Site Related Reaction, Caustic Injury, Chemical Injury, Deformity, Pain, Venous Injury
on Jun 21, 2010 Male patient from UNITED STATES , 42 years of age, weighting 190.0 lb, was treated with Phenergan (View Usage). After Phenergan was administered, patient had the following side effects: catheter site related reaction, caustic injury, chemical injury, deformity, pain (What is pain?), venous injury. Phenergan dosage: .

6727839-1 | Injection Site Mass, Injection Site Pain, Pain In Extremity
on May 14, 2010 Female patient from UNITED STATES , 35 years of age, weighting 316.0 lb, was diagnosed with nausea (What is nausea?) and was treated with Phenergan (View Usage). Patient experienced the following unwanted or unexpected effects: injection site mass, injection site pain, pain in extremity. Phenergan dosage: .

6683406-X | Compartment Syndrome, Complex Regional Pain Syndrome, Corynebacterium Infection, Cyanosis, Erythema, Muscle Contracture, Neuroma, Neuropathy Peripheral, Oedema Peripheral
Patient was taking Phenergan (View Usage). Patient had the following side effects: compartment syndrome, complex regional pain syndrome (What is complex regional pain syndrome?), corynebacterium infection, cyanosis, erythema, muscle contracture, neuroma, neuropathy peripheral, oedema peripheral on Apr 06, 2010 from UNITED STATES Additional patient health information: Female patient , 55 years of age, was diagnosed with nausea (What is nausea?), diabetes mellitus and. Phenergan dosage: . During the same period patient was treated with REGLAN (View Reglan Review and Reglan Label ), JANUVIA (View Januvia Review and Januvia Label ), ACCUPRIL (View Accupril Review and Accupril Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), SINGULAIR (View Singulair Review and Singulair Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

6337016-4 | Confusional State, Dry Gangrene, Injection Site Erythema, Injection Site Extravasation, Necrosis, Neuropathy Peripheral, Pain In Extremity, Paraesthesia, Peripheral Coldness
Adverse event was reported on Aug 21, 2009 by a Female patient taking Phenergan (View Usage) (Dosage: ) was diagnosed with nausea (What is nausea?), back pain (What is back pain?), dehydration, anxiety (What is anxiety?), fluid replacement, injection site erythema and. Location: UNITED STATES , 60 years of age, weighting 123.5 lb, After Phenergan was administered, patient had the following side effects: confusional state, dry gangrene, injection site erythema, injection site extravasation, necrosis, neuropathy peripheral, pain in extremity, paraesthesia, peripheral coldness. During the same period patient was treated with MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ), SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (View Sodium Chloride 0.9% In Plastic Container Review and Sodium Chloride 0.9% In Plastic Container Label ), ATIVAN (View Ativan Review and Ativan Label ), DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER (View Dextrose 5% And Sodium Chloride 0.45% In Plastic Container Review and Dextrose 5% And Sodium Chloride 0.45% In Plastic Container Label ), DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ), DARVOCET N 100 (View Darvocet-n 100 Review and Darvocet-n 100 Label ).

6315503-2 | Activities Of Daily Living Impaired, Depressed Level Of Consciousness, Dysarthria, Fatigue, Feeling Abnormal, Injection Site Phlebitis, Muscle Twitching, Paraesthesia
on Aug 10, 2009 Male patient from UNITED STATES , 51 years of age, was diagnosed with nausea (What is nausea?) and was treated with Phenergan (View Usage). Patient experienced the following unwanted or unexpected effects: activities of daily living impaired, depressed level of consciousness, dysarthria, fatigue, feeling abnormal, injection site phlebitis, muscle twitching, paraesthesia. Phenergan dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), KELP (View Kelp Review and Kelp Label ), COQ10 (View Coq10 Review and Coq10 Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

6312005-4 | Extremity Necrosis, Gangrene, Infusion Site Necrosis, Infusion Site Pain, Peripheral Coldness
on Aug 07, 2009 Female patient from UNITED STATES , 60 years of age, was treated with Phenergan (View Usage). Patient had the following side effects: extremity necrosis, gangrene, infusion site necrosis, infusion site pain, peripheral coldness. Phenergan dosage: . During the same period patient was treated with MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ), SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (View Sodium Chloride 0.9% In Plastic Container Review and Sodium Chloride 0.9% In Plastic Container Label ), DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), EFFEXOR (View Effexor Review and Effexor Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ).

6250274-X | Nausea, Pruritus
Patient was taking Phenergan (View Usage). After Phenergan was administered, patient had the following side effects: nausea (What is nausea?), pruritus on Jun 26, 2009 from UNITED STATES Additional patient health information: Male patient , 33 years of age, weighting 150.0 lb, was diagnosed with nausea (What is nausea?), pain (What is pain?) and. Phenergan dosage: 25 Mg Q6 Prn Iv. During the same period patient was treated with DILAUDID (View Dilaudid Review and Dilaudid Label ).

6231864-7 | Injection Site Irritation, Injection Site Pain, Pain In Extremity, Vein Disorder
Adverse event was reported on Jun 12, 2009 by a Female patient taking Phenergan (View Usage) (Dosage: ? 2?) was diagnosed with procedural nausea and. Location: UNITED STATES , 41 years of age, weighting 170.0 lb, Patient experienced the following unwanted or unexpected effects: injection site irritation, injection site pain, pain in extremity, vein disorder.

6198756-3 | Injection Site Extravasation, Injection Site Reaction, Pseudomonas Infection, Skin Necrosis
on May 13, 2009 Female patient from UNITED STATES , 48 years of age, was diagnosed with nausea (What is nausea?), hypocalcaemia, hypertension and was treated with Phenergan (View Usage). Patient had the following side effects: injection site extravasation, injection site reaction, pseudomonas infection, skin necrosis. Phenergan dosage: . During the same period patient was treated with CALCITRIOL (View Calcitriol Review and Calcitriol Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), NORVASC (View Norvasc Review and Norvasc Label ), CALCIUM ACETATE (View Calcium Acetate Review and Calcium Acetate Label ), CALCIUM CARBONATE W/VITAMIN D NOS (View Calcium Carbonate W/vitamin D Nos Review and Calcium Carbonate W/vitamin D Nos Label ), COREG (View Coreg Review and Coreg Label ), CLONIDINE (View Clonidine Review and Clonidine Label ). Patient was hospitalized.

6181053-X | Amnesia, Cerebrovascular Accident, Contusion, Dystonia, Fall, Laceration
on May 04, 2009 Male patient from UNITED STATES , 87 years of age, weighting 170.0 lb, was diagnosed with nausea (What is nausea?), vertigo and was treated with Phenergan (View Usage). After Phenergan was administered, patient had the following side effects: amnesia, cerebrovascular accident, contusion, dystonia (What is dystonia?), fall (What is fall?), laceration. Phenergan dosage: . Patient was hospitalized.

6166682-1 | Abnormal Behaviour, Disorientation, Fear, Hallucination, Oxygen Saturation Decreased, Panic Reaction, Respiration Abnormal, Respiratory Depression, Screaming
Patient was taking Phenergan (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, disorientation, fear, hallucination, oxygen saturation decreased, panic reaction, respiration abnormal, respiratory depression, screaming on Apr 23, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 102.0 lb, was diagnosed with procedural nausea and. Phenergan dosage: 25 Mg Once Iv Drip.

6165494-2 | Abnormal Behaviour, Frequent Bowel Movements, Insomnia
Adverse event was reported on Apr 21, 2009 by a Male patient taking Phenergan (View Usage) (Dosage: ) was diagnosed with nausea (What is nausea?) and. Location: UNITED STATES , 92 years of age, weighting 160.0 lb, Patient had the following side effects: abnormal behaviour, frequent bowel movements, insomnia.

6146879-7 | Cellulitis, Hypoaesthesia, Injection Site Irritation, Musculoskeletal Stiffness, Pain, Venous Thrombosis Limb
on Apr 06, 2009 Female patient from UNITED STATES , weighting 140.0 lb, was diagnosed with nausea (What is nausea?) and was treated with Phenergan (View Usage). After Phenergan was administered, patient had the following side effects: cellulitis (What is cellulitis?), hypoaesthesia, injection site irritation, musculoskeletal stiffness, pain (What is pain?), venous thrombosis limb. Phenergan dosage: Iv Push.

6127682-0 | Blastocystis Infection, Clostridium Difficile Colitis, Depressed Level Of Consciousness, Mental Status Changes, Urinary Tract Infection Fungal
on Mar 11, 2009 Female patient from UNITED STATES , 57 years of age, was diagnosed with nausea (What is nausea?), insomnia, back pain (What is back pain?), muscle spasms, intercostal neuralgia and was treated with Phenergan (View Usage). Patient experienced the following unwanted or unexpected effects: blastocystis infection, clostridium difficile colitis, depressed level of consciousness, mental status changes, urinary tract infection fungal. Phenergan dosage: 25 Mg Every 6 Hours As Needed. During the same period patient was treated with AMBIEN (10 Mg, Qhs As Needed) (View Ambien Review and Ambien Label ), CYCLOBENZAPRINE (2.5 Mg, Twice Daily As Needed) (View Cyclobenzaprine Review and Cyclobenzaprine Label ), LUNESTA (3 Mg Qhs As Needed) (View Lunesta Review and Lunesta Label ), OPANA ER (View Opana Er Review and Opana Er Label ), ZANAFLEX (2.5 Mg Twice As Day As Needed) (View Zanaflex Review and Zanaflex Label ), XANAX (View Xanax Review and Xanax Label ), TOPAMAX (View Topamax Review and Topamax Label ). Patient was hospitalized.

6122245-5 | Amnesia, Blood Pressure Decreased, Coma, Diarrhoea, Heart Rate Increased, Hyperthermia Malignant, Hypoaesthesia, Hypoventilation
Patient was taking Phenergan (View Usage). Patient had the following side effects: amnesia, blood pressure decreased, coma, diarrhoea, heart rate increased, hyperthermia malignant, hypoaesthesia, hypoventilation on Mar 16, 2009 from UNITED STATES Additional patient health information: Female patient , 61 years of age, weighting 170.0 lb, was diagnosed with influenza, nausea (What is nausea?) and. Phenergan dosage: . Patient was hospitalized.

6058871-1 | Blister, Oedema Peripheral, Peripheral Coldness
Adverse event was reported on Jan 28, 2009 by a Female patient taking Phenergan (View Usage) (Dosage: 50 Mg Once Intra-arterial) was diagnosed with migraine (What is migraine?) and. Location: UNITED STATES , 40 years of age, After Phenergan was administered, patient had the following side effects: blister, oedema peripheral, peripheral coldness. During the same period patient was treated with DEMEROL (View Demerol Review and Demerol Label ). Patient was hospitalized.

5948443-9 | Amnesia, Delirium, Myoclonus, Neuroleptic Malignant Syndrome
on Nov 10, 2008 Female patient from UNITED STATES , weighting 132.3 lb, was diagnosed with gastroenteritis (What is gastroenteritis?) and was treated with Phenergan (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, delirium, myoclonus, neuroleptic malignant syndrome. Phenergan dosage: 25mg Once Im. Patient was hospitalized.

5926942-3 | Dysarthria, Erythema, Incoherent, Tremor
on Oct 21, 2008 Female patient from UNITED STATES , weighting 220.0 lb, was diagnosed with nausea (What is nausea?) and was treated with Phenergan (View Usage). Patient had the following side effects: dysarthria, erythema, incoherent, tremor. Phenergan dosage: Once Iv.

5904322-4 | Agitation, Confusional State, Disorientation, Injection Site Irritation, Moaning, Muscle Twitching, Paraesthesia, Speech Disorder
Patient was taking Phenergan (View Usage). After Phenergan was administered, patient had the following side effects: agitation, confusional state, disorientation, injection site irritation, moaning, muscle twitching, paraesthesia, speech disorder on Sep 30, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 189.6 lb, was diagnosed with nausea (What is nausea?) and. Phenergan dosage: 12.5mg X 1 Dose Iv, 1 Dose Only. Patient was hospitalized.

5825035-3 | Infusion Related Reaction, Infusion Site Swelling, Nerve Injury, Pain In Extremity, Thrombosis, Vein Discolouration
Adverse event was reported on Jul 25, 2008 by a Female patient taking Phenergan (View Usage) (Dosage: ) was diagnosed with nausea (What is nausea?) and. Location: UNITED STATES , 31 years of age, weighting 112.0 lb, Patient experienced the following unwanted or unexpected effects: infusion related reaction, infusion site swelling, nerve injury, pain in extremity, thrombosis, vein discolouration.

5724623-2 | Anxiety, Hallucination, Nausea
on Apr 30, 2008 Female patient from UNITED STATES , 31 years of age, weighting 136.7 lb, was diagnosed with vomiting and was treated with Phenergan (View Usage). Patient had the following side effects: anxiety (What is anxiety?), hallucination, nausea (What is nausea?). Phenergan dosage: 25mg Ivpb X 1. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), VALACYCLOVIR (View Valacyclovir Review and Valacyclovir Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ).

5723946-0 | Anaphylactic Reaction, Anoxia, Cardiac Arrest, Post Procedural Complication
on Apr 22, 2008 Female patient from UNITED STATES , 45 years of age, was diagnosed with pruritus, procedural pain and was treated with Phenergan (View Usage). After Phenergan was administered, patient had the following side effects: anaphylactic reaction, anoxia, cardiac arrest (What is cardiac arrest?), post procedural complication. Phenergan dosage: . During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ), OPIOIDS (View Opioids Review and Opioids Label ).

5713906-8 | Convulsion
Patient was taking Phenergan (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion on Apr 22, 2008 from UNITED STATES Additional patient health information: Female patient , 36 years of age, weighting 112.0 lb, was diagnosed with impaired gastric emptying, gastrointestinal motility disorder, nausea (What is nausea?) and. Phenergan dosage: 25 Mg Evening Before Bed Po.

5707145-4 | Blood Pressure Immeasurable, Cardio-respiratory Arrest, Convulsion, Pulse Absent, Unresponsive To Stimuli
Adverse event was reported on Apr 14, 2008 by a Male patient taking Phenergan (View Usage) (Dosage: 6.25 Mg Once Iv) was diagnosed with nausea (What is nausea?) and. Location: UNITED STATES , 86 years of age, weighting 172.0 lb, Patient had the following side effects: blood pressure immeasurable, cardio-respiratory arrest, convulsion, pulse absent, unresponsive to stimuli. During the same period patient was treated with LEVAQUIN (View Levaquin Review and Levaquin Label ), BICALUTAMIDE (View Bicalutamide Review and Bicalutamide Label ), CENTRUM SILVER MULTI VITAMIN (View Centrum Silver Multi-vitamin Review and Centrum Silver Multi-vitamin Label ), DOCUSATE (View Docusate Review and Docusate Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ).

5520800-4 | Tremor
on Nov 16, 2007 Female patient from UNITED STATES , 41 years of age, was diagnosed with nausea (What is nausea?) and was treated with Phenergan (View Usage). After Phenergan was administered, patient had the following side effects: tremor. Phenergan dosage: 25mg Prn Q4-6 Iv Push. During the same period patient was treated with XANAX (View Xanax Review and Xanax Label ), TOPAMAX (View Topamax Review and Topamax Label ), LOXITANE (View Loxitane Review and Loxitane Label ), DEMEROL (View Demerol Review and Demerol Label ), GI MIXTURE OR (View Gi Mixture Or Review and Gi Mixture Or Label ).

5485467-2 | Abnormal Behaviour, Burning Sensation, Dehydration, Dyskinesia, Hypoaesthesia, Nausea, Neuralgia, Oedema Peripheral, Pain In Extremity
on Oct 10, 2007 Female patient from UNITED STATES , weighting 249.0 lb, was diagnosed with nausea (What is nausea?) and was treated with Phenergan (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, burning sensation, dehydration, dyskinesia, hypoaesthesia, nausea (What is nausea?), neuralgia, oedema peripheral, pain in extremity. Phenergan dosage: One Time Im.

5476814-6 | Condition Aggravated, Muscle Spasms, Restlessness
Patient was taking Phenergan (View Usage). Patient had the following side effects: condition aggravated, muscle spasms, restlessness on Oct 03, 2007 from UNITED STATES Additional patient health information: Female patient , 80 years of age, weighting 154.3 lb, was diagnosed with anxiety (What is anxiety?) and. Phenergan dosage: 12.5mg Q4? Prn Iv.

5451243-X | Rash, Urticaria
Adverse event was reported on Sep 11, 2007 by a Male patient taking Phenergan (View Usage) (Dosage: 12.5 Iv) was diagnosed with abdominal pain (What is abdominal pain?) and. Location: UNITED STATES , 31 years of age, weighting 187.5 lb, After Phenergan was administered, patient had the following side effects: rash (What is rash?), urticaria.

5214933-X | Loss Of Consciousness, Respiratory Distress
on Jan 19, 2007 Female patient from UNITED STATES , weighting 89.60 lb, was diagnosed with nausea (What is nausea?) and was treated with Phenergan (View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness, respiratory distress. Phenergan dosage: 25 Mg Once Iv Bolus.

5211898-1 | Aphasia, Speech Disorder
on Jan 16, 2007 Female patient from UNITED STATES , 75 years of age, weighting 110.0 lb, was diagnosed with nausea (What is nausea?) and was treated with Phenergan (View Usage). Patient had the following side effects: aphasia (What is aphasia?), speech disorder. Phenergan dosage: Injection One.

5208891-1 | Impaired Work Ability, Injection Site Irritation, Injection Site Pain, Thrombophlebitis Superficial
Patient was taking Phenergan (View Usage). After Phenergan was administered, patient had the following side effects: impaired work ability, injection site irritation, injection site pain, thrombophlebitis superficial on Jan 11, 2007 from UNITED STATES Additional patient health information: Male patient , 35 years of age, weighting 155.0 lb, was diagnosed with nausea (What is nausea?) and. Phenergan dosage: Every 6 Hours Iv.

5168633-5 | Rash
Adverse event was reported on Dec 06, 2006 by a Male patient taking Phenergan (View Usage) (Dosage: ) . Location: UNITED STATES , 48 years of age, weighting 194.7 lb, Patient experienced the following unwanted or unexpected effects: rash (What is rash?).

5163803-4 | Arm Amputation, Arterial Spasm, Gangrene, Poor Peripheral Circulation
on Nov 29, 2006 Female patient from UNITED STATES , 83 years of age, weighting 89.00 lb, was diagnosed with nausea (What is nausea?) and was treated with Phenergan (View Usage). Patient had the following side effects: arm amputation, arterial spasm, gangrene, poor peripheral circulation. Phenergan dosage: 12.5 Mg Intra-arter. Patient was hospitalized.

5162922-6 | Blood Albumin Decreased, Blood Alkaline Phosphatase Increased
on Nov 27, 2006 Female patient from UNITED STATES , 58 years of age, weighting 110.0 lb, was treated with Phenergan (View Usage). After Phenergan was administered, patient had the following side effects: blood albumin decreased, blood alkaline phosphatase increased. Phenergan dosage: 25 Mg Prn Q6h. During the same period patient was treated with ZOFRAN (View Zofran Review and Zofran Label ), NEULASTA (6 Mg/0.6 Ml Subq. Self Administration On 12-oct-2006) (View Neulasta Review and Neulasta Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), LASIX (View Lasix Review and Lasix Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), LORTAB (10 Mg Qid Prn) (View Lortab Review and Lortab Label ).

5155949-1 | Intentional Overdose
Patient was taking Phenergan (View Usage). Patient experienced the following unwanted or unexpected effects: intentional overdose on Nov 01, 2006 from UNITED STATES Additional patient health information: Female patient , 28 years of age, . Phenergan dosage: . During the same period patient was treated with COCAINE (COCAINE) (View Cocaine (cocaine) Review and Cocaine (cocaine) Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ).

5155948-X | Intentional Overdose
Adverse event was reported on Nov 01, 2006 by a Female patient taking Phenergan (View Usage) (Dosage: ) . Location: UNITED STATES , 19 years of age, Patient had the following side effects: intentional overdose. During the same period patient was treated with COCAINE (COCAINE) (View Cocaine (cocaine) Review and Cocaine (cocaine) Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ).

5155775-3 | Intentional Overdose
on Nov 01, 2006 Female patient from UNITED STATES , 19 years of age, was treated with Phenergan (View Usage). After Phenergan was administered, patient had the following side effects: intentional overdose. Phenergan dosage: . During the same period patient was treated with COCAINE (COCAINE) (View Cocaine (cocaine) Review and Cocaine (cocaine) Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ).

5153251-5 | Erythema, Finger Amputation, Gangrene, Iatrogenic Injury, Infusion Site Pain, Local Swelling, Peripheral Coldness, Rash Macular
on Nov 14, 2006 Female patient from UNITED STATES , 32 years of age, was treated with Phenergan (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, finger amputation, gangrene, iatrogenic injury, infusion site pain, local swelling, peripheral coldness, rash macular. Phenergan dosage: Injectable.

5130282-2 | Amnesia, Dementia, Hallucination, Loss Of Consciousness, Mental Disorder
Patient was taking Phenergan (View Usage). Patient had the following side effects: amnesia, dementia (What is dementia?), hallucination, loss of consciousness, mental disorder on Oct 18, 2006 from UNITED STATES Additional patient health information: Female patient , 85 years of age, weighting 125.0 lb, . Phenergan dosage: . Patient was hospitalized.